David Randall, DPM
Podiatrist · Provo, UTNPI 1710976535
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,587 of the $3,563 with a category attached, or 72.6%. 21 manufacturers reported payments, led by Paragon 28, Inc. at 38.0% of the total. 2025 is the largest year on record at $1,482, 5.5 times the $267 reported in 2019.
Across 102 payments — averaging $34.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$1K
- Smith+Nephew$667
- Stryker$411
- Organogenesis Inc.$370
- Treace Medical Concepts, Inc.$171
- Kerecis Limited$102
- plus $490 from 15 others
What the payments were for
- Travel & lodging$97627%
- Food & beverage$2,58773%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 13 | $1,353 |
| Smith+Nephew | 34 | $667 |
| Stryker | 9 | $411 |
| Organogenesis Inc. | 13 | $370 |
| Treace Medical Concepts, Inc. | 10 | $171 |
| Kerecis Limited | 3 | $102 |
| Heron Therapeutics, Inc. | 3 | $97 |
| Summit Surgical Corp. | 1 | $54 |
| Averitas Pharma Inc. | 2 | $53 |
| Amgen | 2 | $52 |
| Zimmer Biomet | 1 | $51 |
| Bioventus LLC | 2 | $44 |
| Nevro Corp. | 1 | $26 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Abbott | 1 | $16 |
| GRT US Holding, Inc. | 1 | $15 |
| Medtronic | 1 | $15 |
| Inari Medical, Inc. | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Merck | 1 | $11 |
| Advanced Oxygen Therapy Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Bun-Yo-Matic$516
- Portfolio$507
- SALVATION$127
- PuraPly$118
- Grafix$107
- GRAFIX PL$107
- Stravix$107
- ORTHOLOC 2 LAPIFUSE$102
How this compares
$3,563 in reported general payments places this provider in the 80th percentile of 59 podiatrist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 21 | $668 |
| Ciclopirox | 19 | $612 |
| Fluconazole | 68 | $499 |
| CiclopiroxCiclopirox Olamine | 23 | $488 |
| Diclofenac Sodium | 12 | $393 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 14 | $289 |
| Ammonium Lactate | 15 | $222 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Provo
- Jared CleggProvo$2K
- Thomas RogersProvo$913
- Jason BruseLayton$203K
- Anna HronekSalt Lake City$82K
- Michele CarrDraper$56K
- David GraffOgden$39K
- Clark LarsenMurray$16K
- Kelly HamblinWest Jordan$13K
- Mikol AndersonSalt Lake City$9K
- Thomas EddyMurray$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.